Bin Liang

1.5k total citations
98 papers, 1.0k citations indexed

About

Bin Liang is a scholar working on Hepatology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Bin Liang has authored 98 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Hepatology, 26 papers in Surgery and 20 papers in Pathology and Forensic Medicine. Recurrent topics in Bin Liang's work include Hepatocellular Carcinoma Treatment and Prognosis (46 papers), Cancer Mechanisms and Therapy (17 papers) and Cancer, Hypoxia, and Metabolism (15 papers). Bin Liang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (46 papers), Cancer Mechanisms and Therapy (17 papers) and Cancer, Hypoxia, and Metabolism (15 papers). Bin Liang collaborates with scholars based in China, United States and Armenia. Bin Liang's co-authors include Chuansheng Zheng, Bin Xiong, Xuefeng Kan, Haohao Lu, Huimin Liang, Yong Wang, Yingjiang Ye, Yanyan Cao, Youli Wang and Jun Qu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Radiology.

In The Last Decade

Bin Liang

89 papers receiving 998 citations

Peers

Bin Liang

HEPAT

PRM

SURGE

ONCOL

Wentao Wang China

Jianjun Luo China

Qiang He China

Zhenhua Hu China

Amedeo Carraro Italy

Ioanna Delladetsima Greece

Kohei Horioka Japan

Rashmi Agni United States

Sun Hong Yoo South Korea

Shan Ke China

Wentao Wang China

Bin Liang

265 ×0.7

HEPAT

127 ×0.5

PRM

315 ×1.5

SURGE

138 ×1.0

79 ×0.6

ONCOL

Citations per year, relative to Bin Liang Bin Liang (= 1×) peers Wentao Wang

Countries citing papers authored by Bin Liang

Since Specialization

Citations

This map shows the geographic impact of Bin Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Liang more than expected).

Fields of papers citing papers by Bin Liang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bin Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Liang. The network helps show where Bin Liang may publish in the future.

Co-authorship network of co-authors of Bin Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Bin Liang. A scholar is included among the top collaborators of Bin Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bin Liang. Bin Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Guilin, Yanqiao Ren, Jiayun Liu, et al.. (2025). Transarterial Chemoembolization Plus Radiofrequency Ablation and Iodine-125 Seed Implantation for Hepatocellular Carcinoma in High-Risk Locations: A Propensity Score-Matched Analysis. Journal of Hepatocellular Carcinoma. Volume 12. 15–27.

Zhang, Lijie, Tao Sun, Bo Sun, et al.. (2024). Utility and predictive value of the CRAFITY score in advanced hepatocellular carcinoma treated with transarterial chemoembolization plus tyrosine kinase inhibitors and PD-1 inhibitor. BMC Cancer. 24(1). 223–223. 6 indexed citations

Liu, Ziyi, Lijie Zhang, Qing Li, et al.. (2024). Transcatheter Arterial Embolization with Bleomycin-Lipiodol of Hepatic Hemangiomas: Safety, Efficacy and Predictors of Response. CardioVascular and Interventional Radiology. 47(7). 931–942. 3 indexed citations

Wang, Zizhuo, et al.. (2024). Hypoxia as a Target for Combination with Transarterial Chemoembolization in Hepatocellular Carcinoma. Pharmaceuticals. 17(8). 1057–1057. 5 indexed citations

Lu, Haohao, et al.. (2024). Prospective Comparison of Conventional CTA With Angiography-CT for Identification of Culprit Systemic Arteries in Patients Undergoing Bronchial Artery Embolization for Hemoptysis. American Journal of Roentgenology. 223(4). e2431515–e2431515.

Zhang, Lijie, Xi Long, Xiaoyu Han, et al.. (2024). Detecting Cellular Microstructural Changes of Liver Fibrosis with Time-Dependent Diffusion MRI. Radiology. 313(1). e240343–e240343. 6 indexed citations

Sun, Tao, Jiayun Liu, Yanyan Cao, et al.. (2024). Radiofrequency hyperthermia enhances the effect of OK-432 for Hepatocellular carcinoma by activating of TLR4-cGAS-STING pathway. International Immunopharmacology. 130. 111769–111769. 7 indexed citations

Chen, Lei, Linxia Wu, Lijie Zhang, et al.. (2024). Effect of metformin on hepatocellular carcinoma patients with type II diabetes receiving transarterial chemoembolization: a multicenter retrospective cohort study. International Journal of Surgery. 111(1). 828–838. 14 indexed citations

Lu, Haohao, et al.. (2023). Efficacy and safety analysis of TACE + Donafenib + Toripalimab versus TACE + Sorafenib in the treatment of unresectable hepatocellular carcinoma: a retrospective study. BMC Cancer. 23(1). 1033–1033. 10 indexed citations

10.

Li, Yan, Jiaping Li, Bin Liang, et al.. (2023). A Phase 1/2 Multicenter Randomized Trial of Local Ablation plus Toripalimab versus Toripalimab Alone for Previously Treated Unresectable Hepatocellular Carcinoma. Clinical Cancer Research. 29(15). 2816–2825. 14 indexed citations

11.

Zhang, Siqi, Xiaohong Chen, Yaoju Tan, et al.. (2023). Quantification of Isoniazid-Heteroresistant Mycobacterium tuberculosis Using Droplet Digital PCR. Journal of Clinical Microbiology. 61(6). e0188422–e0188422. 10 indexed citations

12.

Lu, Haohao, et al.. (2023). Efficacy and safety analysis of dexamethasone + palonosetron in prevention of post-embolization syndrome after D-TACE: A retrospective study. Medicine. 102(40). e35433–e35433. 6 indexed citations

13.

Lu, Haohao, Chuansheng Zheng, Bin Liang, & Bin Xiong. (2022). Efficacy and Safety of Lobaplatin-TACE in the Treatment of Primary HepatocellularCarcinoma: A Retrospective Study. Anti-Cancer Agents in Medicinal Chemistry. 23(4). 461–469. 2 indexed citations

14.

Zhang, Lijie, Qing Li, Dan Zhao, et al.. (2021). Transjugular intrahepatic portosystemic shunt for hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum. BMC Gastroenterology. 21(1). 26–26. 5 indexed citations

15.

Liang, Bin, Hua Xiang, Cong Ma, et al.. (2020). <p>Comparison of chemoembolization with CalliSpheres® microspheres and conventional chemoembolization in the treatment of hepatocellular carcinoma: a multicenter retrospective study</p>. Cancer Management and Research. Volume 12. 941–956. 22 indexed citations

16.

Chen, Lei, Xuefeng Kan, Tao Sun, et al.. (2020). Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma. BMC Gastroenterology. 20(1). 205–205. 13 indexed citations

17.

An, Jusheng, et al.. (2019). Long-Term Survival and Late Toxicity Associated With Pelvic Intensity Modulated Radiation Therapy (IMRT) for Cervical Cancer Involving CT-Based Positive Lymph Nodes. Frontiers in Oncology. 9. 520–520. 18 indexed citations

18.

Feng, Jian, et al.. (2018). Diagnosis and treatment for severe hemorrhage of portal vein system after pancreaticoduodenectomy. 7(6). 482–485.

19.

Zhang, Song, et al.. (2014). Primary choriocarcinoma in mediastinum with multiple lung metastases in a male patient: A case report and a review of the literature. Thoracic Cancer. 5(5). 463–467. 9 indexed citations

20.

Deng, Xiaoying, Yuting Zheng, Xiaoming Wang, et al.. (1993). The hypoxic moderation of systemic hypertension in spontaneously hypertensive rats.. PubMed. 8(3). 125–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact